# An Evaluation of the Adrenal Suppression Potential and PK of CB-03-01 Cream in Pediatric Patients With Acne Vulgaris

> **NCT02720627** · PHASE2 · COMPLETED · sponsor: **Cassiopea SpA** · enrollment: 27 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** cortexolone 17α-propionate

## Key facts

- **NCT ID:** NCT02720627
- **Lead sponsor:** Cassiopea SpA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-28
- **Primary completion:** 2018-03-21
- **Final completion:** 2018-03-21
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2020-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02720627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02720627, "An Evaluation of the Adrenal Suppression Potential and PK of CB-03-01 Cream in Pediatric Patients With Acne Vulgaris". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02720627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*